Methods and compositions for treating cancers using antisense
AssigneeThomas Jefferson University
InventorsDavid W. Andrews, Douglas C. Hooper
Life of this patent
Estimating the term…
Loading patent…
AssigneeThomas Jefferson University
InventorsDavid W. Andrews, Douglas C. Hooper
Estimating the term…
The present disclosure relates to compositions and methods for treating cancers using antisense (AS) nucleic acids directed against Insulin-like Growth Factor 1 Receptor (IGF-1R). The AS may be administered to the patients systemically, or may be used to produce an autologous cancer cell vaccine. In embodiments, the AS are provided in an implantable irradiated biodiffusion chamber comprising tumor cells and an effective amount of the AS. The chambers are irradiated and implanted in the abdomen of subjects and stimulate an immune response that attacks tumors distally. The compositions and methods disclosed herein may be used to treat many different kinds of cancer, for example glioblastoma.
A method of vaccinating a subject having a brain cancer comprising:
A biodiffusion chamber for implantation into a subject having brain cancer, the biodiffusion chamber comprising:
Dependencies are inferred from the claim text.